User: Guest

E-CLINICAL TRIAL TECHNOLOGIES

Global Market Trajectory & Analytics

MCP-6744

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

2502
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

452
Interactions with Platform & by Email

PARTICIPANTS

73
Unique # Participated

VALIDATIONS

33
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

AUGUST 2020

TABLES

60

PAGES

175

EDITION

15

PRICE

USD $5600


GLOBAL EXECUTIVE SURVEY

Impact of Pandemic & Economic Slowdown

Monitor Market Dynamics!

Early March 2020, we reached out to senior enterprise executives who are driving strategy, business development, marketing, sales, product management, technology and operations at competitive firms worldwide. Our ongoing survey is focused on how this will this affect their business ecosystems. We invite you to participate in our survey and add to collective perspectives. Market movements are tracked for 2020, 2021 and broadly for the period of 2022 through 2025. Critical changes are monitored dynamically for the rest of this year. Updated analytics will reflect new and evolving market realities. Our first update scheduled for May 2020 and another in the Fall. Clients receive complimentary updates during 2020. If your company is a recent client for this project, we may have already reached out to your colleagues to participate in our program. If you're an active player in the space but hasn't yet subscribed to our project, we invite you to participate and share your perspectives. Please sign-up here.

Amid the COVID-19 crisis, the global market for e-Clinical Trial Technologies estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$9.9 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027. EDC, one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RTSM segment is readjusted to a revised 8.1% CAGR for the next 7-year period.
The e-Clinical Trial Technologies market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.2% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.
In the global CTMS segment, USA, Canada, Japan, China and Europe will drive the 10.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$971 Million in the year 2020 will reach a projected size of US$2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.1 Billion by the year 2027.We bring years of research experience to this 15th edition of our report. The 175-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
BioClinica; Bio-Optronics; CRF Health; Datatrak International; e-Clinical solutions Inc.; ERT; MaxisIT; Medidata Solutions; OmniComm Systems; Oracle Corporation; PAREXEL International Corporation
» Application (EDC, RTSM, CTMS, ePROs)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
A Prelude
Cost-Containment: An Important Factor Increasing the Uptake of e-Clinical Trial Technologies
Global Market Overview
Outsourcing of Clinical Studies to Developing Countries Benefits Market
Globalization Boosts e-Clinical Trials Market
Key Challenges for e-Clinical Trials
Role of Contract Research Organizations (CROs) in Clinical Activity
Global Competitor Market Shares
e-Clinical Trial Technologies Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Surging Global Population Offers Increased Growth Opportunities
Pharmaceutical Firms and CROs to Drive Adoption Rate
Rise in Clinical Trial Complexities Propels e-Clinical Trial Technologies Demand
CROs - The Targeted Customers for e-Clinical Trial Technologies
Increased Importance of e-Clinical Integration
Big Data and Patient Centricity: Areas to Increase Focus Upon
Esource Documentation Witnesses Increased Traction
Increased Adoption of electronic Trial Master File (eTMFs)
Risk-Based Monitoring Witnesses New Modifications
Growing Implementation of e-Consent
Increased Investments in Virtual Clinical Trials
Open Source - Emerging Solutions in Clinical Trials Domain
Mobile Technologies to Help Trial Operators in Tackling Challenges
Smartphones & Tablets: The New Age ePRO Devices
4. GLOBAL MARKET PERSPECTIVE
e-Clinical Trial Technologies Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
e-Clinical Trial Technologies Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
e-Clinical Trial Technologies Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
EDC (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
EDC (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
EDC (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
RTSM (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
RTSM (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
RTSM (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
CTMS (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
CTMS (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
CTMS (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
ePROs (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
ePROs (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
ePROs (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US e-Clinical Trial Technologies Market Share (in %) by Company: 2018 & 2025
United States e-Clinical Trial Technologies Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
e-Clinical Trial Technologies Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
e-Clinical Trial Technologies Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
Canada
Canadian e-Clinical Trial Technologies Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
e-Clinical Trial Technologies Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
Canadian e-Clinical Trial Technologies Market Share Analysis by Application: 2012 VS 2020 VS 2027
Japan
Japanese Demand Estimates and Forecasts for e-Clinical Trial Technologies in US$ Million by Application: 2020 to 2027
Japanese e-Clinical Trial Technologies Market in US$ Million by Application: 2012-2019
e-Clinical Trial Technologies Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
China
Chinese Demand for e-Clinical Trial Technologies in US$ Million by Application: 2020 to 2027
e-Clinical Trial Technologies Market Review in China in US$ Million by Application: 2012-2019
Chinese e-Clinical Trial Technologies Market Share Breakdown by Application: 2012 VS 2020 VS 2027
Europe
Market Facts & Figures
European e-Clinical Trial Technologies Market: Competitor Market Share Scenario (in %) for 2018 & 2025
European e-Clinical Trial Technologies Market Demand Scenario in US$ Million by Region/Country: 2020-2027
e-Clinical Trial Technologies Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
European e-Clinical Trial Technologies Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
European e-Clinical Trial Technologies Addressable Market Opportunity in US$ Million by Application: 2020-2027
e-Clinical Trial Technologies Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
European e-Clinical Trial Technologies Market Share Analysis by Application: 2012 VS 2020 VS 2027
France
e-Clinical Trial Technologies Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
French e-Clinical Trial Technologies Historic Market Review in US$ Million by Application: 2012-2019
French e-Clinical Trial Technologies Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
Germany
e-Clinical Trial Technologies Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
German e-Clinical Trial Technologies Market in Retrospect in US$ Million by Application: 2012-2019
e-Clinical Trial Technologies Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
Italy
Italian Demand for e-Clinical Trial Technologies in US$ Million by Application: 2020 to 2027
e-Clinical Trial Technologies Market Review in Italy in US$ Million by Application: 2012-2019
Italian e-Clinical Trial Technologies Market Share Breakdown by Application: 2012 VS 2020 VS 2027
United Kingdom
United Kingdom Demand Estimates and Forecasts for e-Clinical Trial Technologies in US$ Million by Application: 2020 to 2027
United Kingdom e-Clinical Trial Technologies Market in US$ Million by Application: 2012-2019
e-Clinical Trial Technologies Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
Rest of Europe
Rest of Europe e-Clinical Trial Technologies Addressable Market Opportunity in US$ Million by Application: 2020-2027
e-Clinical Trial Technologies Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
Rest of Europe e-Clinical Trial Technologies Market Share Analysis by Application: 2012 VS 2020 VS 2027
Asia-Pacific
e-Clinical Trial Technologies Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
Asia-Pacific e-Clinical Trial Technologies Historic Market Review in US$ Million by Application: 2012-2019
Asia-Pacific e-Clinical Trial Technologies Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
Rest of World
Rest of World e-Clinical Trial Technologies Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
e-Clinical Trial Technologies Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
Rest of World e-Clinical Trial Technologies Market Share Analysis by Application: 2012 VS 2020 VS 2027
Total Companies Profiled : 85

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com